These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension. Swift AJ; Capener D; Johns C; Hamilton N; Rothman A; Elliot C; Condliffe R; Charalampopoulos A; Rajaram S; Lawrie A; Campbell MJ; Wild JM; Kiely DG Am J Respir Crit Care Med; 2017 Jul; 196(2):228-239. PubMed ID: 28328237 [TBL] [Abstract][Full Text] [Related]
6. Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular Assessment. Alandejani F; Hameed A; Tubman E; Alabed S; Shahin Y; Lewis RA; Dwivedi K; Mahmood A; Middleton J; Watson L; Alkhanfar D; Johns CS; Rajaram S; Garg P; Condliffe R; Elliot CA; Thompson AAR; Rothman AMK; Charalampopoulos A; Lawrie A; Wild JM; Swift AJ; Kiely DG Front Cardiovasc Med; 2022; 9():797561. PubMed ID: 35402574 [TBL] [Abstract][Full Text] [Related]
7. The value of three-dimensional echocardiography in risk stratification in pulmonary arterial hypertension: a cross-sectional study. Liu BY; Wu WC; Zeng QX; Liu ZH; Niu LL; Tian Y; Luo Q; Zhao ZH; Quan RL; Lin JR; Wang H; He JG; Xiong CM Int J Cardiovasc Imaging; 2020 Apr; 36(4):577-584. PubMed ID: 31853819 [TBL] [Abstract][Full Text] [Related]
8. Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial Hypertension. Lewis RA; Billings CG; Hurdman JA; Smith IA; Austin M; Armstrong IJ; Middleton J; Rothman AMK; Harrington J; Hamilton N; Hameed AG; Thompson AAR; Charalampopoulos A; Elliot CA; Lawrie A; Sabroe I; Wild JM; Swift AJ; Condliffe R; Kiely DG Ann Am Thorac Soc; 2021 Jan; 18(1):34-43. PubMed ID: 32926635 [No Abstract] [Full Text] [Related]
9. Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. Alabed S; Shahin Y; Garg P; Alandejani F; Johns CS; Lewis RA; Condliffe R; Wild JM; Kiely DG; Swift AJ JACC Cardiovasc Imaging; 2021 May; 14(5):931-942. PubMed ID: 33008758 [TBL] [Abstract][Full Text] [Related]
10. Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response. Goh ZM; Balasubramanian N; Alabed S; Dwivedi K; Shahin Y; Rothman AMK; Garg P; Lawrie A; Capener D; Thompson AAR; Alandejani F; Wild JM; Johns CS; Lewis RA; Gosling R; Sharkey M; Condliffe R; Kiely DG; Swift AJ Heart; 2022 Aug; 108(17):1392-1400. PubMed ID: 35512982 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease. Rajaram S; Swift AJ; Capener D; Elliot CA; Condliffe R; Davies C; Hill C; Hurdman J; Kidling R; Akil M; Wild JM; Kiely DG J Rheumatol; 2012 Jun; 39(6):1265-74. PubMed ID: 22589263 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension. Yokokawa T; Boucherat O; Martineau S; Lemay SE; Breuils-Bonnet S; Krishna V; Kalyana-Sundaram S; Jeyaseelan J; Potus F; Bonnet S; Provencher S J Am Heart Assoc; 2024 Jun; 13(12):e032888. PubMed ID: 38874078 [TBL] [Abstract][Full Text] [Related]
14. A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines. Dardi F; Manes A; Guarino D; Zuffa E; De Lorenzis A; Magnani I; Rotunno M; Ballerini A; Lo Russo GV; Nardi E; Galiè N; Palazzini M Open Heart; 2021 Oct; 8(2):. PubMed ID: 34667092 [TBL] [Abstract][Full Text] [Related]
15. Right ventricular-vascular coupling ratio in pediatric pulmonary arterial hypertension: A comparison between cardiac magnetic resonance and right heart catheterization measurements. Breeman KTN; Dufva M; Ploegstra MJ; Kheyfets V; Willems TP; Wigger J; Hunter KS; Ivy DD; Berger RMF; Truong U Int J Cardiol; 2019 Oct; 293():211-217. PubMed ID: 31109778 [TBL] [Abstract][Full Text] [Related]
16. Quantification of biventricular strain and assessment of ventriculo-ventricular interaction in pulmonary arterial hypertension using exercise cardiac magnetic resonance imaging and myocardial feature tracking. Lin ACW; Seale H; Hamilton-Craig C; Morris NR; Strugnell W J Magn Reson Imaging; 2019 May; 49(5):1427-1436. PubMed ID: 30353959 [TBL] [Abstract][Full Text] [Related]
17. Influence of long-standing pulmonary arterial hypertension and its severity on pulmonary artery aneurysm development. Nuche J; Montero-Cabezas JM; Lareo A; Huertas S; Jiménez López-Guarch C; Velázquez Martín M; Alonso Charterina S; Revilla Ostolaza Y; Delgado JF; Arribas Ynsaurriaga F; Escribano Subías P Heart Vessels; 2020 Sep; 35(9):1290-1298. PubMed ID: 32248253 [TBL] [Abstract][Full Text] [Related]
18. Exercise cardiac MRI unmasks right ventricular dysfunction in acute hypoxia and chronic pulmonary arterial hypertension. Jaijee S; Quinlan M; Tokarczuk P; Clemence M; Howard LSGE; Gibbs JSR; O'Regan DP Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H950-H957. PubMed ID: 29775415 [TBL] [Abstract][Full Text] [Related]
19. Impact of Epicardial Adipose Tissue on Right Cardiac Function and Prognosis in Pulmonary Arterial Hypertension. Chen Y; Li J; Li F; Chen Z; Chen Z; Luo J; Qiu H; Chen W; Hu J; Luo X; Tan Y; Rathinasabapathy A; Chen J; Li J Chest; 2024 May; 165(5):1211-1223. PubMed ID: 38040053 [TBL] [Abstract][Full Text] [Related]
20. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension. Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]